These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34919576)

  • 1. Estimating the impact of interventions against COVID-19: From lockdown to vaccination.
    Thompson J; Wattam S
    PLoS One; 2021; 16(12):e0261330. PubMed ID: 34919576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.
    Ngonghala CN; Iboi E; Eikenberry S; Scotch M; MacIntyre CR; Bonds MH; Gumel AB
    Math Biosci; 2020 Jul; 325():108364. PubMed ID: 32360770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of relaxing interventions on human contact patterns and SARS-CoV-2 transmission in China.
    Zhang J; Litvinova M; Liang Y; Zheng W; Shi H; Vespignani A; Viboud C; Ajelli M; Yu H
    Sci Adv; 2021 May; 7(19):. PubMed ID: 33962957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H
    Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling COVID-19 dynamics and potential for herd immunity by vaccination in Austria, Luxembourg and Sweden.
    Kemp F; Proverbio D; Aalto A; Mombaerts L; Fouquier d'Hérouël A; Husch A; Ley C; Gonçalves J; Skupin A; Magni S
    J Theor Biol; 2021 Dec; 530():110874. PubMed ID: 34425136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
    Jentsch PC; Anand M; Bauch CT
    Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical modeling of the transmission of SARS-CoV-2-Evaluating the impact of isolation in São Paulo State (Brazil) and lockdown in Spain associated with protective measures on the epidemic of CoViD-19.
    Yang HM; Lombardi Junior LP; Castro FFM; Yang AC
    PLoS One; 2021; 16(6):e0252271. PubMed ID: 34129608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implications of silent transmission for the control of COVID-19 outbreaks.
    Moghadas SM; Fitzpatrick MC; Sah P; Pandey A; Shoukat A; Singer BH; Galvani AP
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17513-17515. PubMed ID: 32632012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study.
    Panovska-Griffiths J; Kerr CC; Stuart RM; Mistry D; Klein DJ; Viner RM; Bonell C
    Lancet Child Adolesc Health; 2020 Nov; 4(11):817-827. PubMed ID: 32758453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A COVID-19-Based Modified Epidemiological Model and Technological Approaches to Help Vulnerable Individuals Emerge from the Lockdown in the UK.
    Anderez DO; Kanjo E; Pogrebna G; Kaiwartya O; Johnson SD; Hunt JA
    Sensors (Basel); 2020 Sep; 20(17):. PubMed ID: 32887338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Well the Government of Nepal Is Responding to COVID-19? An Experience From a Resource-Limited Country to Confront Unprecedented Pandemic.
    Rayamajhee B; Pokhrel A; Syangtan G; Khadka S; Lama B; Rawal LB; Mehata S; Mishra SK; Pokhrel R; Yadav UN
    Front Public Health; 2021; 9():597808. PubMed ID: 33681124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2.
    Sanz-Leon P; Hamilton LHW; Raison SJ; Pan AJX; Stevenson NJ; Stuart RM; Abeysuriya RG; Kerr CC; Lambert SB; Roberts JA
    Philos Trans A Math Phys Eng Sci; 2022 Oct; 380(2233):20210311. PubMed ID: 35965469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term strategies to control COVID-19 in low and middle-income countries: an options overview of community-based, non-pharmacological interventions.
    Chowdhury R; Luhar S; Khan N; Choudhury SR; Matin I; Franco OH
    Eur J Epidemiol; 2020 Aug; 35(8):743-748. PubMed ID: 32656618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could masks curtail the post-lockdown resurgence of COVID-19 in the US?
    Ngonghala CN; Iboi EA; Gumel AB
    Math Biosci; 2020 Nov; 329():108452. PubMed ID: 32818515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
    Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M;
    Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.